Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maneka Puligandla

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cancer|May 9, 2019
An updated analysis of 4 randomized ECOG trials of high-dose interferon in the adjuvant treatment of melanomaYana G Najjar, Maneka Puligandla, Sandra J Lee, et al.
JCI Insight|January 19, 2017
Protein disulfide isomerase inhibition blocks thrombin generation in humans by interfering with platelet factor V activationJack D Stopa, Donna Neuberg, Maneka Puligandla, et al.
British Journal of Haematology|December 6, 2019
Sudden death in sickle cell disease: current experienceChijioke Nze, Brooke Fortin, Revital Freedman, et al.
The Journal of Urology|August 22, 2018
Patterns of Relapse and Implications for Post-Nephrectomy Surveillance in Patients with High Risk Nonclear Cell Renal Cell Carcinoma: Subgroup Analysis of the Phase 3 ECOG-ACRIN E2805 TrialVivek Narayan, Maneka Puligandla, Naomi B Haas, et al.
Blood|May 5, 2017
Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparinCharlene Mantia, Erik J Uhlmann, Maneka Puligandla, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Anticoagulation after intracranial hemorrhage in brain tumors: Risk of recurrent hemorrhage and venous thromboembolismBrian J Carney, Erik J Uhlmann, Maneka Puligandla, et al.
Cancer Medicine|August 18, 2021
Adherence to oral therapies among patients with renal cell carcinoma: Post hoc analysis of the ECOG-ACRIN E2805 trialCaitlin C Murphy, Hannah M Fullington, David E Gerber, et al.
Journal of Thrombosis and Thrombolysis|September 27, 2018
Postoperative bridging anticoagulation and left ventricular assist system thrombosisDavid M Nemer, Garrick C Stewart, Maneka Puligandla, et al.
Plos One|July 6, 2019
Contrast-enhanced ultrasound detects changes in microvascular blood flow in adults with sickle cell diseaseJonathan R Lindner, Todd Belcik, Michael Widlansky, et al.
Blood Advances|May 23, 2020
Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trialJeffrey I Zwicker, Joanna Roopkumar, Maneka Puligandla, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cancer|May 9, 2019
An updated analysis of 4 randomized ECOG trials of high-dose interferon in the adjuvant treatment of melanomaYana G Najjar, Maneka Puligandla, Sandra J Lee, et al.
JCI Insight|January 19, 2017
Protein disulfide isomerase inhibition blocks thrombin generation in humans by interfering with platelet factor V activationJack D Stopa, Donna Neuberg, Maneka Puligandla, et al.
British Journal of Haematology|December 6, 2019
Sudden death in sickle cell disease: current experienceChijioke Nze, Brooke Fortin, Revital Freedman, et al.
The Journal of Urology|August 22, 2018
Patterns of Relapse and Implications for Post-Nephrectomy Surveillance in Patients with High Risk Nonclear Cell Renal Cell Carcinoma: Subgroup Analysis of the Phase 3 ECOG-ACRIN E2805 TrialVivek Narayan, Maneka Puligandla, Naomi B Haas, et al.
Blood|May 5, 2017
Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparinCharlene Mantia, Erik J Uhlmann, Maneka Puligandla, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Anticoagulation after intracranial hemorrhage in brain tumors: Risk of recurrent hemorrhage and venous thromboembolismBrian J Carney, Erik J Uhlmann, Maneka Puligandla, et al.
Cancer Medicine|August 18, 2021
Adherence to oral therapies among patients with renal cell carcinoma: Post hoc analysis of the ECOG-ACRIN E2805 trialCaitlin C Murphy, Hannah M Fullington, David E Gerber, et al.
Journal of Thrombosis and Thrombolysis|September 27, 2018
Postoperative bridging anticoagulation and left ventricular assist system thrombosisDavid M Nemer, Garrick C Stewart, Maneka Puligandla, et al.
Plos One|July 6, 2019
Contrast-enhanced ultrasound detects changes in microvascular blood flow in adults with sickle cell diseaseJonathan R Lindner, Todd Belcik, Michael Widlansky, et al.
Blood Advances|May 23, 2020
Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trialJeffrey I Zwicker, Joanna Roopkumar, Maneka Puligandla, et al.
Pageof 3